Counselors in Hardin, MT Accepting Medicare
6 Counselors found. Showing 1 - 6
 Kenneth Dean, LCPC Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 16 N Miles Ave Ste 101, Hardin, MT 59034 Phone: 406-665-4103 |
Robert He Does It, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 809 N Custer Ave, Hardin, MT 59034 Phone: 406-531-9697 |
 Ms. Pamela Joan Ponich-hunthausen, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1223 N Center Ave, Hardin, MT 59034 Phone: 406-665-4103 |
Dr. Michael Ray Tilus, PSYD Counselor - Pastoral Medicare: Accepting Medicare Assignments Practice Location: 10 4th St W, Hardin, MT 59034 Phone: 406-867-4105 Fax: 406-867-4102 |
Ms. Natalie Kim Real Bird, MS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 10 W 4th Street Suite B, Big Horn Valley Health Center, Hardin, MT 59034 Phone: 406-665-4103 Fax: 406-867-4103 |
Rosalyn Marie Bigback, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 10 4th St W, Hardin, MT 59034 Phone: 406-867-4105 Fax: 406-867-4103 |
News Archive
Study: Kinship caregivers receive fewer support services than foster parents
Children who are placed with a relative because of mistreatment at home fare better in some areas than those placed in foster care, but they may have a higher risk of substance use and teenage pregnancy.
Max Planck scientists aim to analyze the whole mouse brain under electron microscope
What happens in the brain when we see, hear, think and remember? To be able to answer questions like this, neuroscientists need information about how the millions of neurons in the brain are connected to each other.
Novel nanoengineered retinal prosthesis may help restore eyesight
A team of engineers at the University of California San Diego and La Jolla-based startup Nanovision Biosciences Inc. have developed the nanotechnology and wireless electronics for a new type of retinal prosthesis that brings research a step closer to restoring the ability of neurons in the retina to respond to light.
New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUS study demonstrating an association between early tumor shrinkage and long-term median overall survival (OS) of more than 2 years for patients with KRAS wild-type metastatic colorectal cancer (mCRC) treated with Erbitux® (cetuximab) plus FOLFOX standard chemotherapy.
› Verified 2 days ago